irbesartan and hydrochlorothiazide
Generic: irbesartan and hydrochlorothiazide
Labeler: teva pharmaceuticals usa, inc.Drug Facts
Product Profile
Brand Name
irbesartan and hydrochlorothiazide
Generic Name
irbesartan and hydrochlorothiazide
Labeler
teva pharmaceuticals usa, inc.
Dosage Form
TABLET, FILM COATED
Routes
Active Ingredients
hydrochlorothiazide 12.5 mg/1, irbesartan 150 mg/1
Manufacturer
Identifiers & Regulatory
Product NDC
0093-8238
Product ID
0093-8238_af80b0d1-ba9d-4d3c-849c-6c7c1a7cfade
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
ANDA
Application Number
ANDA077369
Listing Expiration
2027-12-31
Marketing Start
2013-01-24
Pharmacologic Class
Established (EPC)
Mechanism of Action
Chemical Structure
Physiologic Effect
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
00938238
Hyphenated Format
0093-8238
Supplemental Identifiers
RxCUI
UPC
UNII
NUI
Packaging Origin
Original Packager
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
irbesartan and hydrochlorothiazide (source: ndc)
Generic Name
irbesartan and hydrochlorothiazide (source: ndc)
Application Number
ANDA077369 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 12.5 mg/1
- 150 mg/1
Packaging
- 30 TABLET, FILM COATED in 1 BOTTLE (0093-8238-56)
- 90 TABLET, FILM COATED in 1 BOTTLE (0093-8238-98)
Packages (2)
Ingredients (2)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "af80b0d1-ba9d-4d3c-849c-6c7c1a7cfade", "openfda": {"nui": ["N0000175359", "N0000175419", "M0471776", "N0000000070", "N0000175561"], "upc": ["0300938238569"], "unii": ["0J48LPH2TH", "J0E2756Z7N"], "rxcui": ["310792", "310793"], "spl_set_id": ["83f4acc1-697a-4770-b554-1b9a8fb5de74"], "pharm_class_cs": ["Thiazides [CS]"], "pharm_class_pe": ["Increased Diuresis [PE]"], "pharm_class_epc": ["Thiazide Diuretic [EPC]", "Angiotensin 2 Receptor Blocker [EPC]"], "pharm_class_moa": ["Angiotensin 2 Receptor Antagonists [MoA]"], "manufacturer_name": ["Teva Pharmaceuticals USA, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET, FILM COATED in 1 BOTTLE (0093-8238-56)", "package_ndc": "0093-8238-56", "marketing_start_date": "20130124"}, {"sample": false, "description": "90 TABLET, FILM COATED in 1 BOTTLE (0093-8238-98)", "package_ndc": "0093-8238-98", "marketing_start_date": "20130220"}], "brand_name": "Irbesartan and Hydrochlorothiazide", "product_id": "0093-8238_af80b0d1-ba9d-4d3c-849c-6c7c1a7cfade", "dosage_form": "TABLET, FILM COATED", "pharm_class": ["Angiotensin 2 Receptor Antagonists [MoA]", "Angiotensin 2 Receptor Blocker [EPC]", "Increased Diuresis [PE]", "Thiazide Diuretic [EPC]", "Thiazides [CS]"], "product_ndc": "0093-8238", "generic_name": "Irbesartan and Hydrochlorothiazide", "labeler_name": "Teva Pharmaceuticals USA, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Irbesartan and Hydrochlorothiazide", "active_ingredients": [{"name": "HYDROCHLOROTHIAZIDE", "strength": "12.5 mg/1"}, {"name": "IRBESARTAN", "strength": "150 mg/1"}], "application_number": "ANDA077369", "marketing_category": "ANDA", "marketing_start_date": "20130124", "listing_expiration_date": "20271231"}